Monday, July 13, 2026
Preview mode — showing bulk-ingested data not yet promoted to production. Hide preview

FDA · United States

sodium ferric gluconate complex — FDA regulatory status

sodium ferric gluconate complex (FERRLECIT) regulatory status in the United States is tracked from public FDA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: FDA approved.

Status snapshot

Status
FDA approved
Brand
FERRLECIT
Mechanism
Supplement
Structured fields
5

Pharmacology context used for competitive intelligence: Supplement. This page is a status aggregation for professional reference — not prescribing advice.

Regional decision snapshot — FDA: approved.

Linked evidence on this spoke: 11 published clinical programs and 0 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.

Regulatory timeline

Regulator Region Status Date Source
FDA United States approved Evidence

Linked clinical programs

Related hubs

FAQ

What is the FDA approval status of sodium ferric gluconate complex?

sodium ferric gluconate complex currently shows FDA approved in our United States regulatory index. Confirm on the official FDA label or EPAR before clinical or commercial use.

Where does NovaPharmaNews get sodium ferric gluconate complex regulatory data?

Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.

How many clinical programs are linked to sodium ferric gluconate complex?

This spoke lists 11 published programs associated with sodium ferric gluconate complex in our pipeline index.